Market Tracker

03/27 7:45pm ET

Synageva BioPharma Corp (NASDAQ:GEVA)

98.69
Delayed Data
As of Mar 27
 +6.02 / +6.50%
Today’s Change
60.19
Today|||52-Week Range
122.88
+6.36%
Year-to-Date

Today’s Trading

Previous close92.67
Today’s open92.86
Day’s range92.86 - 101.22
Volume628,053
Average volume (3 months)338,968
Market cap$3.6B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-73.24%
Earnings growth (this year)-27.52%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-51.46%
P/E ratioNM
Price/Sales467.65
Price/Book6.96

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+2.73+2.44%
CTLTCatalent Inc0.000.00%
XONIntrexon Corp+3.63+9.22%
KITEKite Pharma Inc+2.03+3.52%
Data as of 4:02pm ET, 03/27/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$1.69
Annual revenue (last year)$6.5M
Annual profit (last year)-$192.6M
Net profit margin-2,967.47%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts